 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.6.3.2.19
- Ubiquitin--protein ligase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
ATP + ubiquitin + protein lysine = AMP + diphosphate + protein N-ubiquityllysine
|
 |
 |
 |
 |
 |
ATP
|
+
|
ubiquitin
|
+
|
protein lysine
|
=
|
AMP
|
+
|
diphosphate
|
+
|
protein N-ubiquityllysine
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
cytosol
|
3 terms
|
 |
|
Biological process
|
cell cycle
|
19 terms
|
 |
|
Biochemical function
|
nucleotide binding
|
6 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Biol Chem
277:21913-21921
(2002)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural and functional analysis of the human mitotic-specific ubiquitin-conjugating enzyme, UbcH10.
|
|
Y.Lin,
W.C.Hwang,
R.Basavappa.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Cell cycle progression is controlled at several different junctures by the
targeted destruction of cell cycle regulatory proteins. These carefully
orchestrated events include the destruction of the securin protein to permit
entry into anaphase, and the destruction of cyclin B to permit exit from
mitosis. These destruction events are mediated by the ubiquitin/proteasome
system. The human ubiquitin-conjugating enzyme, UbcH10, is an essential mediator
of the mitotic destruction events. We report here the 1.95-A crystal structure
of a mutant UbcH10, in which the active site cysteine has been replaced with a
serine. Functional analysis indicates that the mutant is active in accepting
ubiquitin, although not as efficiently as wild-type. Examination of the crystal
structure reveals that the NH2-terminal extension in UbcH10 is disordered and
that a conserved 3(10)-helix places a lysine residue near the active site.
Analysis of relevant mutants demonstrates that for ubiquitin-adduct formation
the presence or absence of the NH2-terminal extension has little effect, whereas
the lysine residue near the active site has significant effect. The structure
provides additional insight into UbcH10 function including possible sites of
interaction with the anaphase promoting complex/cyclosome and the disposition of
a putative destruction box motif in the structure.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 5.
Fig. 5. The 3[10] helix situated near the active site
(divergent stereoview). The molecular surface was calculated
using all residues except those in the 3[10] helix (residues
115-119). The residues forming the 3[10] helix are shown in
ball-and-stick representation. The geometry of the 3[10] helix
allows the hydrophobic residues in the helix to pack primarily
against non-polar interior residues, whereas the hydrophilic
residues are substantially solvent exposed. The polar residue
Lys119 is seen to be proximal to the active site thiol
(indicated by the dark patch). The small inset -carbon
trace shows the overall perspective from which the main figure
was made. The 3[10] helix and active site residue are indicated
by thicker segments.
|
 |
Figure 7.
Fig. 7. Candidate sites of interaction with the APC/C.
The relative positions of the active site ( red) and the likely
site of APC11 interaction (residues Tyr91 and Ala^124) are shown
in the left figure. The right figure is related to the left
figure by a rotation of 180° about a vertical axis in the
plane of the paper. The colored and labeled patches are residues
that are conserved only among mitotic Ubcs. The color coding is
as follows: red, blue, yellow, and brown correspond to acidic,
basic, polar, and hydrophobic residues, respectively. Green
indicates the active site cysteine.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2002,
277,
21913-21921)
copyright 2002.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.G.Eldridge,
and
T.O'Brien
(2010).
Therapeutic strategies within the ubiquitin proteasome system.
|
| |
Cell Death Differ, 17,
4.
|
 |
|
|
|
|
 |
D.M.Wenzel,
K.E.Stoll,
and
R.E.Klevit
(2010).
E2s: structurally economical and functionally replete.
|
| |
Biochem J, 433,
31-42.
|
 |
|
|
|
|
 |
L.Jiang,
Y.Bao,
C.Luo,
G.Hu,
C.Huang,
X.Ding,
K.Sun,
and
Y.Lu
(2010).
Knockdown of ubiquitin-conjugating enzyme E2C/UbcH10 expression by RNA interference inhibits glioma cell proliferation and enhances cell apoptosis in vitro.
|
| |
J Cancer Res Clin Oncol, 136,
211-217.
|
 |
|
|
|
|
 |
S.Chen,
Y.Chen,
C.Hu,
H.Jing,
Y.Cao,
and
X.Liu
(2010).
Association of clinicopathological features with UbcH10 expression in colorectal cancer.
|
| |
J Cancer Res Clin Oncol, 136,
419-426.
|
 |
|
|
|
|
 |
T.Fujita,
H.Ikeda,
N.Taira,
S.Hatoh,
M.Naito,
and
H.Doihara
(2009).
Overexpression of UbcH10 alternates the cell cycle profile and accelerate the tumor proliferation in colon cancer.
|
| |
BMC Cancer, 9,
87.
|
 |
|
|
|
|
 |
Y.Ye,
and
M.Rape
(2009).
Building ubiquitin chains: E2 enzymes at work.
|
| |
Nat Rev Mol Cell Biol, 10,
755-764.
|
 |
|
|
|
|
 |
L.Jin,
A.Williamson,
S.Banerjee,
I.Philipp,
and
M.Rape
(2008).
Mechanism of ubiquitin-chain formation by the human anaphase-promoting complex.
|
| |
Cell, 133,
653-665.
|
 |
|
|
|
|
 |
M.K.Summers,
B.Pan,
K.Mukhyala,
and
P.K.Jackson
(2008).
The unique N terminus of the UbcH10 E2 enzyme controls the threshold for APC activation and enhances checkpoint regulation of the APC.
|
| |
Mol Cell, 31,
544-556.
|
 |
|
|
|
|
 |
S.Gong,
and
T.L.Blundell
(2008).
Discarding functional residues from the substitution table improves predictions of active sites within three-dimensional structures.
|
| |
PLoS Comput Biol, 4,
e1000179.
|
 |
|
|
|
|
 |
T.Ravid,
and
M.Hochstrasser
(2008).
Diversity of degradation signals in the ubiquitin-proteasome system.
|
| |
Nat Rev Mol Cell Biol, 9,
679-690.
|
 |
|
|
|
|
 |
T.Ravid,
and
M.Hochstrasser
(2007).
Autoregulation of an E2 enzyme by ubiquitin-chain assembly on its catalytic residue.
|
| |
Nat Cell Biol, 9,
422-427.
|
 |
|
|
|
|
 |
J.Lin,
D.A.Raoof,
Z.Wang,
M.Y.Lin,
D.G.Thomas,
J.K.Greenson,
T.J.Giordano,
M.B.Orringer,
A.C.Chang,
D.G.Beer,
and
L.Lin
(2006).
Expression and effect of inhibition of the ubiquitin-conjugating enzyme E2C on esophageal adenocarcinoma.
|
| |
Neoplasia, 8,
1062-1071.
|
 |
|
|
|
|
 |
C.Dominguez,
A.M.Bonvin,
G.S.Winkler,
F.M.van Schaik,
H.T.Timmers,
and
R.Boelens
(2004).
Structural model of the UbcH5B/CNOT4 complex revealed by combining NMR, mutagenesis, and docking approaches.
|
| |
Structure, 12,
633-644.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
T.Dandrea,
H.Hellmold,
C.Jonsson,
B.Zhivotovsky,
T.Hofer,
L.Wärngård,
and
I.Cotgreave
(2004).
The transcriptosomal response of human A549 lung cells to a hydrogen peroxide-generating system: relationship to DNA damage, cell cycle arrest, and caspase activation.
|
| |
Free Radic Biol Med, 36,
881-896.
|
 |
|
|
|
|
 |
T.R.Pray,
F.Parlati,
J.Huang,
B.R.Wong,
D.G.Payan,
M.K.Bennett,
S.D.Issakani,
S.Molineaux,
and
S.D.Demo
(2002).
Cell cycle regulatory E3 ubiquitin ligases as anticancer targets.
|
| |
Drug Resist Updat, 5,
249-258.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|